Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19

M. Pohanka

. 2022 ; 22 (19) : . [pub] 20220929

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033253

Coronavirus disease 2019 (COVID-19) is a highly virulent infection that has caused a pandemic since 2019. Early diagnosis of the disease has been recognized as one of the important approaches to minimize the pathological impact and spread of infection. Point-of-care tests proved to be substantial analytical tools, and especially lateral flow immunoassays (lateral flow tests) serve the purpose. In the last few years, biosensors have gained popularity. These are simple but highly sensitive and accurate analytical devices composed from a selective molecule such as an antibody or antigen and a sensor platform. Biosensors would be an advanced alternative to current point-of-care tests for COVID-19 diagnosis and standard laboratory methods as well. Recent discoveries related to point-of-care diagnostic tests for COVID-19, the development of biosensors for specific antibodies and specific virus parts or their genetic information are reviewed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033253
003      
CZ-PrNML
005      
20230131150805.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/s22197423 $2 doi
035    __
$a (PubMed)36236521
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defense, Trebesska 1575, CZ-50001 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000188048356
245    10
$a Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19 / $c M. Pohanka
520    9_
$a Coronavirus disease 2019 (COVID-19) is a highly virulent infection that has caused a pandemic since 2019. Early diagnosis of the disease has been recognized as one of the important approaches to minimize the pathological impact and spread of infection. Point-of-care tests proved to be substantial analytical tools, and especially lateral flow immunoassays (lateral flow tests) serve the purpose. In the last few years, biosensors have gained popularity. These are simple but highly sensitive and accurate analytical devices composed from a selective molecule such as an antibody or antigen and a sensor platform. Biosensors would be an advanced alternative to current point-of-care tests for COVID-19 diagnosis and standard laboratory methods as well. Recent discoveries related to point-of-care diagnostic tests for COVID-19, the development of biosensors for specific antibodies and specific virus parts or their genetic information are reviewed.
650    _2
$a protilátky virové $7 D000914
650    12
$a biosenzitivní techniky $7 D015374
650    12
$a COVID-19 $x diagnóza $7 D000086382
650    _2
$a testování na COVID-19 $7 D000086742
650    _2
$a lidé $7 D006801
650    _2
$a imunoanalýza $7 D007118
650    _2
$a vyšetření u lůžka $7 D019095
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
773    0_
$w MED00008309 $t Sensors (Basel, Switzerland) $x 1424-8220 $g Roč. 22, č. 19 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36236521 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150801 $b ABA008
999    __
$a ok $b bmc $g 1891810 $s 1184588
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 22 $c 19 $e 20220929 $i 1424-8220 $m Sensors $n Sensors Basel $x MED00008309
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace